Kimberly-Clark reported Q4 2024 results with net sales of $4.9 billion, a decrease of 0.8%, but organic sales grew by 2.3%. Adjusted EPS was $1.50, down 0.7% year-over-year. The company's Powering Care strategy drove volume gains and improved product mix, generating significant efficiencies.
Net sales were $4.9 billion, down 0.8 percent, with organic sales growth of 2.3 percent.
Adjusted gross margin was 35.4 percent, up 50 basis points versus the prior year.
Adjusted operating profit was $684 million, up 2.1 percent versus the prior year.
Adjusted earnings per share were $1.50, down 0.7 percent versus prior year.
Kimberly-Clark expects 2025 Organic Sales Growth to outpace the weighted average growth in the categories and countries it competes, which are currently growing at approximately two percent.